Personal data disclosure platform Digi.me has secured $6.1m in a round led by reinsurer Swiss Re.

Aramex led a series B round forWhat3words which also featured Intel Capital, the lead investor in the mapping system developer's November 2015 series A.

Medtekwiz Advisory led the round, which will fund clinical tests for Owlstone Medical's breathalyser in lung and colon cancer diagnostics.

Scottish Investment Bank invests in Strathclyde spinout Mironid's $5.7m series A to support its therapy for degenerative kidney disease, major inflammatory disease and cancer.

The UCL Technology Fund invests in gene therapy company Freeline, which hopes to treat blood diseases such as haemophilia B.

Delft University of Technology-backed venture fund Icos Capital supplies capital to solar technology developer Exasun.

Danone Manifesto Ventures is set to make its first investment, entering talks with food brand Michel et Augustin, reportedly to acquire a stake of up to 40%.

Imperial Innovations has contributed to a series A round for small-molecule oncology treatment developer Storm Therapeutics, a Cambridge spinout.

EMBL Ventures backs Allecra Therapeutics' series B round that will support a phase 2 clinical trial for a therapy aimed at drug-resistant bacteria.